Philip Ashton-Rickardt Says the Next Generation of Medical Breakthroughs Will Need More Scientist-Entrepreneurs
Boston biotech leader Philip Ashton-Rickardt believes more researchers should take their discoveries beyond the laboratory and into the real world, where they can improve lives.
Massachusetts, USA, Jul 10, 2026, ZEX PR WIRE — Philip Ashton-Rickardt, Managing Director and Chief Scientific Officer of BE Therapeutics, is encouraging more scientists to consider entrepreneurship as part of their career journey, arguing that the next generation of medical breakthroughs will depend not only on scientific discovery but also on the people willing to transform those discoveries into real-world treatments.
After more than two decades in academia, including professorships at the University of Chicago and Imperial College London, Ashton-Rickardt decided to leave university research and enter biotech...
